LONDON/NEW YORK (Reuters) - London-listed drugmaker Shire Plc said it was willing to recommend a deal with Takeda Pharmaceutical Co to its shareholders, after the Japanese company sweetened its acquisition offer to 46 billion pounds ($64 billion).
Shire says willing to recommend Takeda's $64 billion offer to shareholders
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться